Drug trial led by Cincinnati researchers gains national media attention

Dr. Evan Stein, director of the Metabolic and Atherosclerosis Research Center in Cincinnati, is leading clinical trials for a new drug candidate (REGN727) that may do a better job of lowering cholesterol than statins, and with fewer side effects. The New York Times and ABC News took notice last month.

Dr. Evan Stein

Study results were published in a recent issue of The New England Journal of Medicine.

“About 5 to 10 percent of people can’t tolerate statins at all, and more can’t tolerate higher doses,” said Dr. Evan A. Stein, director of the Metabolic and Atherosclerosis Research Center in Cincinnati and lead author of the drug trials. “It’s still early in development, but for them this is potentially a most promising alternative.”

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

ChanTest announces newly validated and re-engineered cells, expands portfolio of ion channel and GPCR cell lines | PR Web, July 24, 2014

Alkermes announces initiation of phase 1 clinical study of ALKS 8700 for treatment of multiple sclerosis | Business Wire, July 17, 2014

National Psoriasis Foundation awards grants to two Case Western Reserve University researchers | Science Codex, July 16, 2014

HIV test developed at University Hospitals to be distributed nationally by Utah-based company | Cleveland.com, July 16, 2014

Chemoprevention and colon cancer: an interview with Dr. John Letterio, Case Western Reserve University School of Medicine | News Medical.net, July 16, 2014

Dayton Children’s Hosptial adds Dr. Aranda, bringing new advanced techniques in minimally invasive surgery | Xenia Gazette, July 16, 2014

3Bar Biologics takes cutting-edge technology out to corn fields | Akron Legal News, July 15, 2014

University of Cincinnati report shows need for better data on Ohio’s healthcare workforce | UC Health News, July 15, 2014

McNees recognized as one of the nation’s most-favored IP boutiques | McNees Wallace & Nurick, July 11, 2014

The Wright State University and Premier Health Neuroscience Institute has added Dayton Children’s to its research program | Dayton Business Journal, July 10, 2014

Sparton acquires Electronic Manufacturing Technology, LLC of Irvine, CA | Sparton, July 10, 2014

Cleveland Clinic collaborates Parker Hannifin to develop advanced medical technologies | PR Newswire, July 10, 2014

Austen BioInnovation Institute in Akron gets nearly $5 million in support | Akron Beacon Journal, July 9, 2014

Alkermes announces notices of allowance for U.S. patents for four CNS pipeline candidates | Business Wire, July 9, 2014

Students from Bethel-Tate High School gain valuable biotech job skills with Grant Career Center | WCPO9 Cincinnati, July 8, 2014

Rocket Ventures, the Regional Growth Partnership’s venture capital fund, is restarting its TechConnect networking events | Toledo Blade, July 8, 2014

NanoLogix news: Exhibiting at the Ohio Bioscience Expo and Showcase, receives European patent, working with NASA and Ohio Representative Tim Ryan | BusinessWire, July 8, 2014

CTI Clinical Trial and Consulting Services continues growth, adds seven and promotes three | Cincinnati.com, July 7, 2014

Sequentia rolls out discharge planner to help hospitals, patients navigate extended-care options | MedCity News, July 7, 2014

Cardinal Health continues to support future pharmacists with $2M in scholarships | PR Newswire, July 7, 2014